# Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration

> **NCT03313401** · — · COMPLETED · sponsor: **Ulucanlar Eye Training and Research Hospital** · enrollment: 34 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** Aflibercept
- **DEVICE:** Specular microscopy

## Key facts

- **NCT ID:** NCT03313401
- **Lead sponsor:** Ulucanlar Eye Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-05
- **Final completion:** 2017-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03313401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03313401, "Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03313401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*